Targeting cell signalling pathways such as the phosphoinositide 3-kinase/mammalian target of rapamycin (PI3K/mTOR) pathway has also been shown to downregulate immunosuppressive cells such as T regulatory cells and may have a role in improving ICI efficacy in prostate cancer[125,126]. Here, MTOR is linked to prostate carcinoma.